Home / Research / Publications / Carcinoma of unknown primary (CUP) the role of tumor genomic profiling

Publications

Carcinoma of unknown primary (CUP) the role of tumor genomic profiling

September 2021

– Caris Life Sciences

CUP is a heterogenous group of cancers characterized by early metastatic dissemination from an unknown site of origin.1
Overall survival is a dismal 6-12 months and untreated CUP is associated with a 4 week life expectancy.2,3
A 2014 review of the molecular profile of 1806 cases of CUP within the Caris Life Sciences database identified biomarkers with potential therapeutic benefits in over 96% of cases 4
CUP continues to be a diagnostic and treatment challenge and comprehensive genomic profiling may provide therapeutic insight.

Learn More

Name(Required)

First Last

Company/Institution(Required)

Role/Title(Required)

Email(Required)

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.